Published in Cancer Weekly, October 5th, 2004
"PhytoMedical's entry into biopharmaceutical development is very exciting for all of us, coming on the heels of the company's undertaking to develop a brand-new, plant-derived compound, BDC03," stated Derek J. Cooper, secretary-treasurer of PhytoMedical Technologies.
Named BDC03, the first plant-derived compound to be developed by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.